Company History

  • Sept 2014

    China Biologic increased its equity interests in Guizhou Taibang to 76.23% through purchasing additional interest from a minority shareholder.
  • June-July 2014

    China Biologic sold 920,000 shares of common stock from its treasury stock in a follow-on offering, and raised net proceeds of approximately $33.2 million.
  • Mar 2014

    Guizhou Taibang received the renewed Good Manufacturing Practice ("GMP") certification from China Food and Drug Administration ("CFDA") in respect of its updated plasma production facility.
  • January 2014

    Guizhou Taibang received the renewed Good Manufacturing Practice ("GMP") certification from China Food and Drug Administration ("CFDA") in respect of its updated placenta polypeptide production facility.
FirstPage | PreviousPage | NextPage | LastPage CurrentPageIndex:4 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] 
© 2017 China Biologic Products Holdings, Inc. All Rights Reserved.